By Dennis Ford, Founder & CEO, LSN 

Today, Life Science Nation (LSN) accelerates the funding of early stage life science firms via a Match.com-like sourcing platform for private investment, making CEOs more efficient in their capital raising efforts. The FreeMind Group (FMG) specializes in assisting life science organizations secure non-dilutive funding from US Federal Agencies and Private Foundations. LSN and FMG are experts in early stage private and non-dilutive funding respectively, and this complementary expertise fully supports the early stage financing needs of life science entrepreneurs.  As both of these financing sources are vital to early-stage financing, CEOs benefit from understanding both domains: LSN's 10 categories of private early stage and FMG's governmental non-dilutive funding.

LSN and FMG have been working side by side for years, and recently saw that combining both pools of attendees at their respective conferences could transform each from a one-day event into a two-day conference offering dynamic partnering and compelling financing content to the early-stage CEOs visiting San Francisco during the JP Morgan Healthcare Conference...

Read More

By Lucy Parkinson, Senior Research Manager, LSN 

Here at LSN, we're getting ready to go home for Thanksgiving.  But first, we'd like to thank all our readers, supporters and friends across the global life science industry.  We wouldn't be here without you.

In the spirit of the season, LSN Research welcomes you to the table to share the mandates we've gathered from our recent conversations with investors across the world. This cornucopia of investors are from 6 different nations, and cover every niche of the life science sector - from agriculture to therapeutics to devices to healthcare IT.

Click on the mandates in the sidebar to see what's cooking in the rest of the world.